Translational Science Lead, Liver
- Employer
- Spark Therapeutics
- Location
- Philadelphia, Pennsylvania. Hybrid and remote options available for select opportunities.
- Salary
- Salary not provided
- Closing date
- May 26, 2022
View more
- Discipline
- Life Sciences, Biotechnology
- Organization Type
- Pharma
Job Details
- Develop and implement the translation biomarker strategies for liver-directed assets, participating in the Compound Development Team and Non-Clinical Study Team.
- Serve as a strategic lead for translational science, bridging Clinical and Research groups to reach consensus on the key translational goals and their priorities, both for that program and for the platform/portfolio.
- Define the assays and samples needed to address the key goals.
- Coordinate with Bioanalytics and Therapeutic Areas on new assay development as needed.
- Lead the development of analysis plans, working with Data Sciences, Bioanalytics, and Therapeutic Areas to define the required data elements, the statistical approach, and data visualizations.
- Coordinate the analysis and sharing of translational results with Non-Clinical Study Teams, Asset Teams, and to wider audiences internally and externally.
- Propose cross-study meta-analyses to increase the statistical power of testing platform-based hypotheses.
- Interact with internal and external experts and CROs to ensure that Spark can bring state-of-the-art technology and analysis to our translational plans.
- Make recommendations regarding external collaborations, vendors, and in-house technology as needed to support the translational goals.
- Contribute to the biomarker sections for clinical protocols, investigator brochures, clinical study reports, licensing applications, and other regulatory documents.
-
PhD or MD/PhD in molecular biology, immunology, or related field with a minimum of 12+ years of relevant experience in translational research and/or clinical trial experience, preferably in an industry setting. Statistical and computational biology experience are a major plus.
-
Experience with clinical immunogenicity of therapeutics and / or gene therapy is a plus
Familiarity with techniques frequently used in Spark translational research, such as antibody-based protein detection and quantitation (eg, ELISA, ECL, MSD), ELISpot, flow cytometry, IHC/IF, qPCR.
Excellent written and oral presentation skills.
Experience working with matrixed teams and project management preferred.
- Identify and prioritize scientific questions/hypotheses and the associated assays and analysis plans, balancing them with operational considerations within clinical trials.
- Advise teams on internal vs external data generation and for the latter, the selection of vendor/collaborator
- Provide a portfolio-level perspective to teams to achieve goals beyond those of individual programs.
Please be aware that Spark mandates COVID-19 vaccination of all employees regardless of work location. Accommodations may be made in accordance with applicable law.
Nearest Major Market: Philadelphia
Join the Spark Team
We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our shared mission is to challenge the inevitability of genetic disease by discovering, developing, and delivering treatments in ways unimaginable - until now.
We don't follow footsteps. We create the path.
Company
At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia, lysosomal storage disorders and neurodegenerative diseases.
Founded in March 2013 as a result of the technology and know-how accumulated over two decades at Children’s Hospital of Philadelphia (CHOP), our investigational therapies have the potential to provide long-lasting effects, dramatically and positively changing the lives of patients with conditions where no, or only palliative, therapies exist. Greater understanding of the human genome and genetic abnormalities have allowed our scientists to tailor investigational therapies to patients suffering from very specific genetic diseases. This approach holds great promise in developing effective treatments to a host of inherited diseases. Our initial focus is on treating orphan diseases.
Headquartered in dynamic Philadelphia, we are a diverse, experienced team united in our goal to break down barriers for people and families affected by genetic diseases. As our name suggests, our investigational, one-time therapies are designed to spark healthy biology, and deliver potentially life-altering transformation for people and families affected by genetic disease. Spark is a member of the Roche Group.
- Website
- http://sparktx.com/
- Telephone
- 215-989-1149
- Location
-
3737 Market Street
Suite 1300
Philadelphia
PA
19104
United States
Get job alerts
Create a job alert and receive personalized job recommendations straight to your inbox.
Create alert